United States · Clinical Trials startup
United States · Pahr Therapeutics
Pahr Therapeutics is a clinical stage business, is to create innovative ways to treat pulmonary arterial hypertension.
Funding reportedLast round: Seed
What company datasets say Pahr Therapeutics raised
Funding, as reported
Reported in all$14Min dollars
Last roundSeed
Investors listed3
SEC Form D$4.7M sold, 1 filing, last Jul 2025
Clinical Trials in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Pahr Therapeutics in front of investors. Or tell us what we have wrong.